Categories
Archives
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
Jun
02
Partnering with Patient Communities to Advance HS Awareness and Care
May
30
Recognizing Myasthenia Gravis Month – The Importance of Addressing Unmet Patient Needs
Apr
22
Earth Day 2025: Advancing Our Commitment to a Healthier Planet
Apr
03
UCB presents latest research across leading neurology portfolio at American Academy of Neurology (AAN) meeting 2025
Mar
31
The First UCB US Rare Disease Connect in Neurology (RDCN) Annual Summit Launches at American Academy of Neurology 2025
Mar
28
Join UCB at the MGFA National Patient Conference and Visit Our Experience Room
Mar
27
UCB’s Kassandra Watson and Windy Wang Recognized by Healthcare Businesswomen’s Association (HBA) as Luminary and Rising Star
Mar
19
New data on investigational therapy for thymidine kinase 2 deficiency presented at Muscular Dystrophy Association (MDA) 2025 Conference
Mar
12
Epilepsia Publishes Final Analysis of Open-Label Extension Study of Long-Term Safety and Effectiveness of FINTEPLA® (fenfluramine) in Children and Adults with Dravet Syndrome
